8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Oct 7, 2020 · 5y ago · Accession 0001564590-20-045968
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- 8-K
- Filing date
- Oct 7, 2020
- Report date
- Oct 7, 2020
- Document
- abio-8k_20201007.htm
- Size
- 86 KB